Press Releases

News & Events

January, 2013

Approval of Suclear® (sodium sulfate, potassium sulfate and magnesium sulfate oral solution; PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution)

June, 2011

Braintree awarded the Premier Pinnacle Award

August, 2010

Approval of SUPREP® BOWEL PREP KIT (sodium sulfate, potassium sulfate and magnesium sulfate) Oral Solution (17.5g/3.13g/1.6g) per 6 ounces

July, 2010

Approval of 5 mg HalfLytely® and Bisacodyl Tablet Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablet) With Flavor Packs

October, 2009

Braintree Laboratories, Inc and Ipsen: Ipsen acquires exclusive marketing rights of BLI-800 from Braintree Laboratories, Inc for colonic cleansing before colonoscopy

September, 2007

Approval of 10 mg HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets) With Flavor Packs

October, 2006

MiraLAX® (Polyethylene Glycol 3350, NF Powder) OTC approved 1

June, 2005

Braintree Laboratories, Inc. announces the acquisition of Axid® (nizatidine) Oral Solution from Reliant Pharmaceuticals2

May, 2004

Approval of HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets) With Flavor Packs

August, 2003

Braintree Laboratories, Inc completed transition of the product PhosLo® (Calcium Acetate) to Nabi Biopharmaceuticals3

June, 2003

Approval of NuLYTELY® (PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution) With Flavor Packs

December, 2001

Braintree Laboratories, Inc and its employees present the firefighters of New York City with a brand new state-of-the-art Seagrave Tower Ladder Truck – FDNY Ladder Co. 107

April, 2001

Approval of PhosLo® GelCaps (Calcium Acetate) 667 mg

February, 1999

Approval of MiraLax® (Polyethylene Glycol 3350, NF Powder)

April, 1991

Approval of NuLYTELY® (PEG-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution)

December, 1990

Approval of PhosLo® (Calcium Acetate tablets) 667mg 3

July, 1984

Approval of the first oral lavage solution, GoLYTELY® (PEG-3350 and Electrolytes for Oral Solution)

1 MiraLAX is a registered trademark of Merck, Inc.
2 Axid is a registered trademark GlaxoSmithKline, LLC
3 PhosLo is a registered trademark of Fresenius North America,Inc.